626 related articles for article (PubMed ID: 21526942)
1. Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance.
Durante-Mangoni E; Zarrilli R
Future Microbiol; 2011 Apr; 6(4):407-22. PubMed ID: 21526942
[TBL] [Abstract][Full Text] [Related]
2. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.
Kempf M; Rolain JM
Int J Antimicrob Agents; 2012 Feb; 39(2):105-14. PubMed ID: 22113193
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic options for Acinetobacter baumannii infections.
Vila J; Pachón J
Expert Opin Pharmacother; 2008 Mar; 9(4):587-99. PubMed ID: 18312160
[TBL] [Abstract][Full Text] [Related]
4. Acinetobacter baumannii: an emerging multidrug-resistant threat.
Gootz TD; Marra A
Expert Rev Anti Infect Ther; 2008 Jun; 6(3):309-25. PubMed ID: 18588496
[TBL] [Abstract][Full Text] [Related]
5. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies.
Cai Y; Chai D; Wang R; Liang B; Bai N
J Antimicrob Chemother; 2012 Jul; 67(7):1607-15. PubMed ID: 22441575
[TBL] [Abstract][Full Text] [Related]
6. [Antibiotic resistance of Acinetobacter baumannii strains isolated from clinical specimens in the "Marius Nasta" Pneumology Institute, Bucharest].
Moisoiu A; Ionită M; Sârbu L; Stoica C; Grigoriu L
Pneumologia; 2014; 63(2):109-11. PubMed ID: 25241558
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic and genetic relationship of Acinetobacter Baumannii isolates.
Trajkovska-Dokic E; Kotevska V; Kaftandzieva A; Jankoska G; Mircevska G; Petrovska M; Panovski N
Prilozi; 2011; 32(2):157-68. PubMed ID: 22286620
[TBL] [Abstract][Full Text] [Related]
8. Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians.
Jain R; Danziger LH
Ann Pharmacother; 2004 Sep; 38(9):1449-59. PubMed ID: 15280512
[TBL] [Abstract][Full Text] [Related]
9. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
[TBL] [Abstract][Full Text] [Related]
10. Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants.
Bahador A; Taheri M; Pourakbari B; Hashemizadeh Z; Rostami H; Mansoori N; Raoofian R
Microb Drug Resist; 2013 Oct; 19(5):397-406. PubMed ID: 23768166
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiology and clinical features of Acinetobacter baumannii infections in humans].
Wisplinghoff H; Seifert H
Berl Munch Tierarztl Wochenschr; 2014; 127(11-12):447-57. PubMed ID: 25872254
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial activity of carbapenem-based combinations againts multidrug-resistant Acinetobacter baumannii.
Pongpech P; Amornnopparattanakul S; Panapakdee S; Fungwithaya S; Nannha P; Dhiraputra C; Leelarasamee A
J Med Assoc Thai; 2010 Feb; 93(2):161-71. PubMed ID: 20301995
[TBL] [Abstract][Full Text] [Related]
13. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.
Maragakis LL; Perl TM
Clin Infect Dis; 2008 Apr; 46(8):1254-63. PubMed ID: 18444865
[TBL] [Abstract][Full Text] [Related]
14. [Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam].
Sayin Kutlu S; Saçar S; Süzer T; Cevahir N; Okke D; Dirgen Caylak S; Turgut H
Mikrobiyol Bul; 2008 Apr; 42(2):353-8. PubMed ID: 18697435
[TBL] [Abstract][Full Text] [Related]
15. Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin.
Rodriguez CH; Bombicino K; Granados G; Nastro M; Vay C; Famiglietti A
Diagn Microbiol Infect Dis; 2009 Oct; 65(2):188-91. PubMed ID: 19748431
[TBL] [Abstract][Full Text] [Related]
16. Molecular findings and antibiotic-resistance in an outbreak of Acinetobacter baumannii in an intensive care unit.
Longo B; Pantosti A; Luzzi I; Tarasi A; Di Sora F; Gallo S; Placanica P; Monaco M; Dionisi AM; Volpe I; Montella F; Cassone A; Rezza G
Ann Ist Super Sanita; 2007; 43(1):83-8. PubMed ID: 17536158
[TBL] [Abstract][Full Text] [Related]
17. Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities.
Zarrilli R; Giannouli M; Tomasone F; Triassi M; Tsakris A
J Infect Dev Ctries; 2009 Jun; 3(5):335-41. PubMed ID: 19759502
[TBL] [Abstract][Full Text] [Related]
18. Confronting multidrug-resistant Acinetobacter baumannii: a review.
Neonakis IK; Spandidos DA; Petinaki E
Int J Antimicrob Agents; 2011 Feb; 37(2):102-9. PubMed ID: 21130607
[TBL] [Abstract][Full Text] [Related]
19. Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital.
Valencia R; Arroyo LA; Conde M; Aldana JM; Torres MJ; Fernández-Cuenca F; Garnacho-Montero J; Cisneros JM; Ortíz C; Pachón J; Aznar J
Infect Control Hosp Epidemiol; 2009 Mar; 30(3):257-63. PubMed ID: 19199531
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of tigecycline alone and in combination with colistin sulfate or sulbactam against carbapenem-susceptible and -resistant Acinetobacter baumannii strains isolated from Intensive Care Units.
Ozbek B; Otük G
Int J Antimicrob Agents; 2010 Aug; 36(2):191-2. PubMed ID: 20537868
[No Abstract] [Full Text] [Related]
[Next] [New Search]
